Apar Kishor Ganti

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

Medicine, Pathology, Head And Neck Cancer +5

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

Apar Kishor Ganti, Alyssa Klein, Ion Cotarla et al. · JAMA Oncology · 2021 · 693 citations · Full text

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Apar Kishor Ganti, Billy W. Loo, M. Bassetti et al. · Journal of the National Comprehensive Cancer Network · 2021 · 431 citations · Full text

Non–Small Cell Lung Cancer

David S. Ettinger, Wallace Akerley, Hossein Borghaei et al. · Journal of the National Comprehensive Cancer Network · 2012 · 359 citations · Full text

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018

Gregory P. Kalemkerian, Billy W. Loo, Wallace Akerley et al. · Journal of the National Comprehensive Cancer Network · 2018 · 294 citations · Full text